摘要:
Embodiments provide devices, preparations and methods for delivering therapeutic agents (TAs) such as clotting factors (CFs, e.g., Factor 8) within the GI tract. Many embodiments provide a swallowable device e.g., a capsule for delivering TAs into the intestinal wall (IW). Embodiments also provide TA preparations configured to be contained within the capsule, advanced from the capsule into the IW and/or surrounding tissue (ST) and degrade to release the TA into the bloodstream to produce a therapeutic effect (e.g., improved clotting). The preparation can be operably coupled to delivery means having a first configuration where the preparation is contained in the capsule and a second configuration where the preparation is advanced out of the capsule into the IW or ST (e.g., the peritoneal cavity). Embodiments are particularly useful for delivery of CFs for treatment of clotting disorders (e.g., hemophilia) where such CFs are poorly absorbed and/or degraded within the GI tract.
摘要:
A blood pump system for persistently increasing the overall diameter and lumen diameter of peripheral veins and arteries by persistently increasing the speed of blood and the wall shear stress in a peripheral vein or artery for a period of time sufficient to result in a persistent increase in the overall diameter and lumen diameter of the vessel is provided. The blood pump system includes a blood pump, blood conduit(s), a control system with optional sensors, and a power source. The pump system is configured to connect to the vascular system in a patient and pump blood at a desired rate and pulsatility. The pumping of blood is monitored and adjusted, as necessary, to maintain the desired elevated blood speed, wall shear stress, and desired pulsatility in the target vessel to optimize the rate and extent of persistent increase in the overall diameter and lumen diameter of the target vessel.
摘要:
It is provided a blood vessel function inspecting apparatus including: a blood vessel diameter measuring portion configured to measure a diameter of a blood vessel; a blood vessel wall thickness measuring portion configured to measure a wall thickness of the blood vessel; and a blood vessel function index value calculating portion configured to calculate a function index value for diagnosing the blood vessel of its function, after releasing of the blood vessel from blood flow obstruction, by dividing an amount of dilatation of said diameter of the blood vessel continuously measured by said blood vessel diameter measuring portion, by the wall thickness measured by said blood vessel wall thickness measuring portion.
摘要:
A blood rheology measurement device measures a blood rheology of blood flowing through an artery inside of a living body from outside of the living body. The blood rheology measurement device has a sensor that detects a flow rate of blood flowing through the artery and a pulsatile displacement that varies with an elapse of time. The pulsatile displacement corresponds to a displacement of the artery in a diameter direction thereof due to expansion and contraction of the artery resulting from a pulsatile motion of the heart. A calculating section calculates the blood rheology of blood flowing through the artery on the basis of the blood flow rate and the pulsatile displacement detected by the sensor.
摘要:
A method that includes a measurement of hemoglobin or hematocrit with a measurement of hemodynamic parameters to monitor and/or control a modality of treatment of a patient suffering from anemia.
摘要:
Systems and methods are described herein to evaluate a candidate medication as it relates to a subject's cardiovascular health. A processing component is employed to measure a first value of one or more cardiovascular markers, via a computer, which are associated with a circulatory system of each subject that is to receive the candidate medication. The candidate medication is administered to each subject and a second value of one or more cardiovascular markers are measured subsequent to the administration as of the candidate medication. Continued testing of the candidate medication can be continued dependent upon the change in the one or more cardiovascular markers.
摘要:
A replaceable magazine for use in an analytic test instrument a plurality of analytic aids on a carrier tape. The analytic aids can be made available in an application position of the magazine by means of the carrier tape. The magazine has a supply reel for holding regions of the carrier tape with unused analytic aids and a take-up reel for holding regions of the carrier tape with used-up analytic aids. The carrier tape can be moved in a spooling direction from the supply reel to the take-up reel. The magazine has a rewind lock of the take-up reel. The magazine has a tape release device, which is configured to make available a take-up reel tape reserve of the carrier tape on the side of the application position facing the take-up reel. The take-up reel tape reserve enables a lifting movement of an analytic aid situated in the application position.
摘要:
A method that includes a measurement of hemoglobin or hematocrit with a measurement of hemodynamic parameters to monitor and/or control a modality of treatment of a patient suffering from anemia.
摘要:
The present invention relates, in general, to lancing elements for use in drawing bodily fluids out of a patient and, more particularly, to an improved lancing element including first and second elements positioned relative to each other such that an incision formed by the first element is held open by the second element and bodily fluids are pulled up the lancing element by surface tension on the first and second lancing elements.
摘要:
A method for determining the viscosity of a fluid flowing through a system at any point in the system whereby the method involves determining a characteristic relationship for the fluid between viscosity and shear rate; obtaining a shear rate of the fluid as it moves through at least one position in the system; and determining the viscosity of fluid at the at least one position by applying the shear rate to the characteristic relationship. Where the system is the circulatory system of a living being, the method includes determining a viscosity-shear rate relationship unique to that individual. Furthermore, the method further entails determining the actual viscosities and shear rates being experienced in selected blood vessels of the living being.